Discover new treatments currently being developed for pancreatic cancer, which has historically been extremely difficult to ...

Effect of ketorolac on serum GDF-15 and IL-8 in patients with pancreatic cancer with cachexia. Nivolumab plus ipilimumab (N+I) in patients (pts) with pancreatic cancer (PC) with BRCA1/2 mutation (mut) ...

Pancreatic cancer is one of the deadliest of all cancers. Only 12% of men diagnosed with pancreatic cancer are alive five ...

Symptoms of pancreatic cancer can be difficult to spot, but the sooner the patient is diagnosed the better prospects they ...

A new advanced form of treatment for one of the deadliest cancers worldwide, pancreatic cancer, may be on its way, research ...

The same mRNA technology behind COVID-19 vaccines is now being used in the fight against cancer, and the University of ...

Adding pamrevlumab to standard chemotherapy did not improve survival in patients with locally advanced pancreatic cancer ...

Clinical outcomes of immunotherapy in metastatic pancreatic carcinoma: A systematic review and meta-analysis. Overall survival (OS) of patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) ...

Ajay Goel, PhD, AGAF, discusses how the development and validation of novel non-invasive biomarkers can improve early detection and ultimately impact patient outcomes for patients.

The addition of high-dose IV vitamin C to standard chemotherapy nearly doubled OS for patients with advanced pancreatic ...

Pancreatic cancer is one of the deadliest of all cancers. Only 12 per cent of men diagnosed with pancreatic cancer are alive five years after diagnosis; for women it is 14 per cent.

Ric Hartig says weight lifting helped him overcome a lifetime of health issues: rheumatoid arthritis, ulcers, shoulder ...